Sanwei Xin'an: It is planned to repurchase shares for 40 million yuan to 80 million yuan
Sanwei Xin'an announced that it intends to repurchase shares with 40 million yuan to 80 million yuan, and the repurchase ** does not exceed 73$33 shares. The repurchased shares are intended to be used for employee stock ownership plans or equity incentives. On the same day, the company announced that it planned to set up a wholly-owned subsidiary in Hong Kong for US$5 million.
Huilun Crystal: The controlling shareholder intends to transfer 10% of the company's shares by agreement
Whalen Crystal announced that it holds 14Xinjiang Huilun, the controlling shareholder of 36%, signed the "Share Transfer Intent Agreement" with Huang Tiange on November 30, 2023, intending to transfer the company held by 2808040,000 ordinary shares (representing 10% of the total share capital of the Company) were transferred to the transferee and persons acting in concert with it. The share transfer involves the change of the controlling shareholder and actual controller of the company.
Youfa Group: 84.9 billion restricted shares will be lifted on December 8].
Youfa Group announced that the total number of ** listed and circulated this time is 84.9 billion shares. The listing and circulation date of this ** is December 8, 2023.
Wanrun shares: The controlling shareholder and actual controller plan to increase their holdings by 8 million shares to 16 million shares and have increased their holdings by 17500,000 shares].
Wanrun Co., Ltd. announced that the company received the "Notice of China Energy Conservation and Environmental Protection Group on Increasing Shareholding in Wanrun Company and Shareholding Plan" on December 1, 2023, and the company's controlling shareholder and actual controller, China Energy Conservation and Environmental Protection Group, hereinafter referred to as "China Energy Conservation"), increased its holdings in the company through centralized bidding on December 1, 2023500,000 shares, with an increase of RMB2,797,850 and an average price of 1599 yuan shares, accounting for 0. of the company's current total share capital of 930,130,215 shares0188%。
Chenxin Pharmaceutical: Terminated the planning of the spin-off of Fodu Pharmaceutical, a holding subsidiary, to be listed on the main board of the Shenzhen ** Stock Exchange and applied for listing on the first board of the Shenzhen ** Stock Exchange
Chenxin Pharmaceutical announced that the board of directors agreed to terminate the planning of the spin-off of Shandong Chenxin Fodu Pharmaceutical Co., Ltd., a holding subsidiary, to the main board of the Shenzhen ** Stock Exchange, and agreed to Fodu Pharmaceutical's application for listing on the national SME share transfer system (**). After the listing of Fodu Pharmaceutical, it will seek to be listed on the Beijing ** Stock Exchange according to the future capital market environment and strategic development needs.